世界の長時間作用型注射剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Long-Acting Injectables Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3464
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、長時間作用型注射剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（中・小分子、大分子）、用途別市場規模（統合失調症、その他精神病性障害）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・長時間作用型注射剤の市場動向
・企業の競争状況、市場シェア
・長時間作用型注射剤の種類別市場規模（中・小分子、大分子）
・長時間作用型注射剤の用途別市場規模（統合失調症、その他精神病性障害）
・長時間作用型注射剤の北米市場規模2016-2027（アメリカ、カナダ）
・長時間作用型注射剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・長時間作用型注射剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・長時間作用型注射剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・長時間作用型注射剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Eli Lilly、Pfizer、GlaxoSmithKline、Johnson & Johnson、Lupin Limited、Zogenix、DURECT、Medincel）
・結論

Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.

Market Analysis and Insights: Global Long-Acting Injectables Market
The global Long-Acting Injectables market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Long-Acting Injectables market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Long-Acting Injectables market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Long-Acting Injectables market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Long-Acting Injectables market.

Global Long-Acting Injectables Scope and Market Size
Long-Acting Injectables market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Long-Acting Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Small and Middle Sized Molecule
Large Sized Molecule

Segment by Application
Schizophrenia
Other Psychotic Disorders

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin Limited
Zogenix
DURECT
Medincel

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Small and Middle Sized Molecule
1.2.3 Large Sized Molecule
1.3 Market by Application
1.3.1 Global Long-Acting Injectables Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Schizophrenia
1.3.3 Other Psychotic Disorders
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Long-Acting Injectables Market Perspective (2016-2027)
2.2 Long-Acting Injectables Growth Trends by Regions
2.2.1 Long-Acting Injectables Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Long-Acting Injectables Historic Market Share by Regions (2016-2021)
2.2.3 Long-Acting Injectables Forecasted Market Size by Regions (2022-2027)
2.3 Long-Acting Injectables Industry Dynamic
2.3.1 Long-Acting Injectables Market Trends
2.3.2 Long-Acting Injectables Market Drivers
2.3.3 Long-Acting Injectables Market Challenges
2.3.4 Long-Acting Injectables Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Long-Acting Injectables Players by Revenue
3.1.1 Global Top Long-Acting Injectables Players by Revenue (2016-2021)
3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2016-2021)
3.2 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Long-Acting Injectables Revenue
3.4 Global Long-Acting Injectables Market Concentration Ratio
3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2020
3.5 Long-Acting Injectables Key Players Head office and Area Served
3.6 Key Players Long-Acting Injectables Product Solution and Service
3.7 Date of Enter into Long-Acting Injectables Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Long-Acting Injectables Breakdown Data by Type
4.1 Global Long-Acting Injectables Historic Market Size by Type (2016-2021)
4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2022-2027)

5 Long-Acting Injectables Breakdown Data by Application
5.1 Global Long-Acting Injectables Historic Market Size by Application (2016-2021)
5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Long-Acting Injectables Market Size (2016-2027)
6.2 North America Long-Acting Injectables Market Size by Type
6.2.1 North America Long-Acting Injectables Market Size by Type (2016-2021)
6.2.2 North America Long-Acting Injectables Market Size by Type (2022-2027)
6.2.3 North America Long-Acting Injectables Market Size by Type (2016-2027)
6.3 North America Long-Acting Injectables Market Size by Application
6.3.1 North America Long-Acting Injectables Market Size by Application (2016-2021)
6.3.2 North America Long-Acting Injectables Market Size by Application (2022-2027)
6.3.3 North America Long-Acting Injectables Market Size by Application (2016-2027)
6.4 North America Long-Acting Injectables Market Size by Country
6.4.1 North America Long-Acting Injectables Market Size by Country (2016-2021)
6.4.2 North America Long-Acting Injectables Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Long-Acting Injectables Market Size (2016-2027)
7.2 Europe Long-Acting Injectables Market Size by Type
7.2.1 Europe Long-Acting Injectables Market Size by Type (2016-2021)
7.2.2 Europe Long-Acting Injectables Market Size by Type (2022-2027)
7.2.3 Europe Long-Acting Injectables Market Size by Type (2016-2027)
7.3 Europe Long-Acting Injectables Market Size by Application
7.3.1 Europe Long-Acting Injectables Market Size by Application (2016-2021)
7.3.2 Europe Long-Acting Injectables Market Size by Application (2022-2027)
7.3.3 Europe Long-Acting Injectables Market Size by Application (2016-2027)
7.4 Europe Long-Acting Injectables Market Size by Country
7.4.1 Europe Long-Acting Injectables Market Size by Country (2016-2021)
7.4.2 Europe Long-Acting Injectables Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Long-Acting Injectables Market Size (2016-2027)
8.2 Asia-Pacific Long-Acting Injectables Market Size by Type
8.2.1 Asia-Pacific Long-Acting Injectables Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Long-Acting Injectables Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Long-Acting Injectables Market Size by Type (2016-2027)
8.3 Asia-Pacific Long-Acting Injectables Market Size by Application
8.3.1 Asia-Pacific Long-Acting Injectables Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Long-Acting Injectables Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Long-Acting Injectables Market Size by Application (2016-2027)
8.4 Asia-Pacific Long-Acting Injectables Market Size by Region
8.4.1 Asia-Pacific Long-Acting Injectables Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Long-Acting Injectables Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Long-Acting Injectables Market Size (2016-2027)
9.2 Latin America Long-Acting Injectables Market Size by Type
9.2.1 Latin America Long-Acting Injectables Market Size by Type (2016-2021)
9.2.2 Latin America Long-Acting Injectables Market Size by Type (2022-2027)
9.2.3 Latin America Long-Acting Injectables Market Size by Type (2016-2027)
9.3 Latin America Long-Acting Injectables Market Size by Application
9.3.1 Latin America Long-Acting Injectables Market Size by Application (2016-2021)
9.3.2 Latin America Long-Acting Injectables Market Size by Application (2022-2027)
9.3.3 Latin America Long-Acting Injectables Market Size by Application (2016-2027)
9.4 Latin America Long-Acting Injectables Market Size by Country
9.4.1 Latin America Long-Acting Injectables Market Size by Country (2016-2021)
9.4.2 Latin America Long-Acting Injectables Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Long-Acting Injectables Market Size (2016-2027)
10.2 Middle East & Africa Long-Acting Injectables Market Size by Type
10.2.1 Middle East & Africa Long-Acting Injectables Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Long-Acting Injectables Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Long-Acting Injectables Market Size by Type (2016-2027)
10.3 Middle East & Africa Long-Acting Injectables Market Size by Application
10.3.1 Middle East & Africa Long-Acting Injectables Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Long-Acting Injectables Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Long-Acting Injectables Market Size by Application (2016-2027)
10.4 Middle East & Africa Long-Acting Injectables Market Size by Country
10.4.1 Middle East & Africa Long-Acting Injectables Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Long-Acting Injectables Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Long-Acting Injectables Introduction
11.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Long-Acting Injectables Introduction
11.2.4 Pfizer Revenue in Long-Acting Injectables Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Long-Acting Injectables Introduction
11.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Long-Acting Injectables Introduction
11.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Details
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Long-Acting Injectables Introduction
11.5.4 Lupin Limited Revenue in Long-Acting Injectables Business (2016-2021)
11.5.5 Lupin Limited Recent Development
11.6 Zogenix
11.6.1 Zogenix Company Details
11.6.2 Zogenix Business Overview
11.6.3 Zogenix Long-Acting Injectables Introduction
11.6.4 Zogenix Revenue in Long-Acting Injectables Business (2016-2021)
11.6.5 Zogenix Recent Development
11.7 DURECT
11.7.1 DURECT Company Details
11.7.2 DURECT Business Overview
11.7.3 DURECT Long-Acting Injectables Introduction
11.7.4 DURECT Revenue in Long-Acting Injectables Business (2016-2021)
11.7.5 DURECT Recent Development
11.8 Medincel
11.8.1 Medincel Company Details
11.8.2 Medincel Business Overview
11.8.3 Medincel Long-Acting Injectables Introduction
11.8.4 Medincel Revenue in Long-Acting Injectables Business (2016-2021)
11.8.5 Medincel Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Long-Acting Injectables Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Small and Middle Sized Molecule
Table 3. Key Players of Large Sized Molecule
Table 4. Global Long-Acting Injectables Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Long-Acting Injectables Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Long-Acting Injectables Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Long-Acting Injectables Market Share by Regions (2016-2021)
Table 8. Global Long-Acting Injectables Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Long-Acting Injectables Market Share by Regions (2022-2027)
Table 10. Long-Acting Injectables Market Trends
Table 11. Long-Acting Injectables Market Drivers
Table 12. Long-Acting Injectables Market Challenges
Table 13. Long-Acting Injectables Market Restraints
Table 14. Global Long-Acting Injectables Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Long-Acting Injectables Market Share by Players (2016-2021)
Table 16. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-Acting Injectables as of 2020)
Table 17. Ranking of Global Top Long-Acting Injectables Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Long-Acting Injectables Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Long-Acting Injectables Product Solution and Service
Table 21. Date of Enter into Long-Acting Injectables Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Long-Acting Injectables Revenue Market Share by Type (2016-2021)
Table 25. Global Long-Acting Injectables Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Long-Acting Injectables Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Long-Acting Injectables Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Long-Acting Injectables Revenue Market Share by Application (2016-2021)
Table 29. Global Long-Acting Injectables Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Long-Acting Injectables Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Long-Acting Injectables Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Long-Acting Injectables Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Long-Acting Injectables Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Long-Acting Injectables Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Long-Acting Injectables Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Long-Acting Injectables Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Long-Acting Injectables Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Long-Acting Injectables Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Long-Acting Injectables Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Long-Acting Injectables Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Long-Acting Injectables Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Long-Acting Injectables Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Long-Acting Injectables Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Long-Acting Injectables Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Long-Acting Injectables Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Long-Acting Injectables Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Long-Acting Injectables Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Long-Acting Injectables Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Long-Acting Injectables Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Long-Acting Injectables Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Long-Acting Injectables Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Long-Acting Injectables Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Long-Acting Injectables Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Long-Acting Injectables Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Long-Acting Injectables Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eli Lilly Company Details
Table 62. Eli Lilly Business Overview
Table 63. Eli Lilly Long-Acting Injectables Product
Table 64. Eli Lilly Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
Table 65. Eli Lilly Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Long-Acting Injectables Product
Table 69. Pfizer Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Long-Acting Injectables Product
Table 74. GlaxoSmithKline Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Long-Acting Injectables Product
Table 79. Johnson & Johnson Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Lupin Limited Company Details
Table 82. Lupin Limited Business Overview
Table 83. Lupin Limited Long-Acting Injectables Product
Table 84. Lupin Limited Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
Table 85. Lupin Limited Recent Development
Table 86. Zogenix Company Details
Table 87. Zogenix Business Overview
Table 88. Zogenix Long-Acting Injectables Product
Table 89. Zogenix Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
Table 90. Zogenix Recent Development
Table 91. DURECT Company Details
Table 92. DURECT Business Overview
Table 93. DURECT Long-Acting Injectables Product
Table 94. DURECT Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
Table 95. DURECT Recent Development
Table 96. Medincel Company Details
Table 97. Medincel Business Overview
Table 98. Medincel Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
Table 99. Medincel Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long-Acting Injectables Market Share by Type: 2020 VS 2027
Figure 2. Small and Middle Sized Molecule Features
Figure 3. Large Sized Molecule Features
Figure 4. Global Long-Acting Injectables Market Share by Application: 2020 VS 2027
Figure 5. Schizophrenia Case Studies
Figure 6. Other Psychotic Disorders Case Studies
Figure 7. Long-Acting Injectables Report Years Considered
Figure 8. Global Long-Acting Injectables Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Long-Acting Injectables Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Long-Acting Injectables Market Share by Regions: 2020 VS 2027
Figure 11. Global Long-Acting Injectables Market Share by Regions (2022-2027)
Figure 12. Global Long-Acting Injectables Market Share by Players in 2020
Figure 13. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-Acting Injectables as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Long-Acting Injectables Revenue in 2020
Figure 15. Global Long-Acting Injectables Revenue Market Share by Type (2016-2021)
Figure 16. Global Long-Acting Injectables Revenue Market Share by Type (2022-2027)
Figure 17. North America Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Long-Acting Injectables Market Share by Type (2016-2027)
Figure 19. North America Long-Acting Injectables Market Share by Application (2016-2027)
Figure 20. North America Long-Acting Injectables Market Share by Country (2016-2027)
Figure 21. United States Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Long-Acting Injectables Market Share by Type (2016-2027)
Figure 25. Europe Long-Acting Injectables Market Share by Application (2016-2027)
Figure 26. Europe Long-Acting Injectables Market Share by Country (2016-2027)
Figure 27. Germany Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Long-Acting Injectables Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Long-Acting Injectables Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Long-Acting Injectables Market Share by Region (2016-2027)
Figure 37. China Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Long-Acting Injectables Market Share by Type (2016-2027)
Figure 45. Latin America Long-Acting Injectables Market Share by Application (2016-2027)
Figure 46. Latin America Long-Acting Injectables Market Share by Country (2016-2027)
Figure 47. Mexico Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Long-Acting Injectables Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Long-Acting Injectables Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Long-Acting Injectables Market Share by Country (2016-2027)
Figure 53. Turkey Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Eli Lilly Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
Figure 57. Pfizer Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
Figure 59. Johnson & Johnson Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
Figure 60. Lupin Limited Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
Figure 61. Zogenix Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
Figure 62. DURECT Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
Figure 63. Medincel Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の長時間作用性β作動薬市場規模・現状・予測（2021年-2027年）

Global Long Acting Beta Agonist Market Size, Status and Forecast 2021-2027
QYR2104Z3460 2021年4月 95Pages
QYResearch社発行の本調査資料では、長時間作用性β作動薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（液体、錠剤）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のロング・トリプルジャンプ装置市場規模・現状・予測（2021年-2027年）

Global Long and Triple Jump Equipments Market Size, Status and Forecast 2021-2027
QYR2104Z3461 2021年4月 95Pages
QYResearch社発行の本調査資料では、ロング・トリプルジャンプ装置のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（砂場カバー、テイクオフボード、ピットレーキ、その他）、用途別市場規模（アマチュア、プロ）、主要地域別市場規模（北米、アメリカ...

世界のロング・トリプルジャンプ装置市場規模・現状・予測（2021年-2027年）

世界の長距離レーダーシステム市場規模・現状・予測（2021年-2027年）

Global Long Radar System Market Size, Status and Forecast 2021-2027
QYR2104Z3462 2021年4月 99Pages
QYResearch社発行の本調査資料では、長距離レーダーシステムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CWレーダー、パルスレーダー）、用途別市場規模（防衛、商業、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の長期療養市場規模・現状・予測（2021年-2027年）

Global Long-Term Care Market Size, Status and Forecast 2021-2027
QYR2104Z3465 2021年4月 98Pages
QYResearch社発行の本調査資料では、長期療養のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（在宅医療、病院、介護、生活支援施設）、用途別市場規模（病院、ナーシングホーム、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の長期療養市場規模・現状・予測（2021年-2027年）

世界の介護＆在宅医療用技術市場規模・現状・予測（2021年-2027年）

Global Technologies for Long-Term Care and Home Healthcare Market Size, Status and Forecast 2021-2027
QYR2104Z5567 2021年4月 93Pages
QYResearch社発行の本調査資料では、介護＆在宅医療用技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遠隔医療技術、安全監視技術）、用途別市場規模（病院、ナーシングホーム、家庭用、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界のロング・ターム・ケア・プロバイダー市場規模・現状・予測（2021年-2027年）

Global Long Term Care Provider Market Size, Status and Forecast 2021-2027
QYR2104Z3463 2021年4月 96Pages
QYResearch社発行の本調査資料では、ロング・ターム・ケア・プロバイダーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（在宅医療、病院、介護、生活支援施設）、用途別市場規模（女性、男性）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の無菌注射製剤市場 2021：企業別、地域別、種類・用途別

Global Sterile Injectables Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z13278 2021年4月 104Pages
当調査資料では、無菌注射製剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。無菌注射製剤の種類別市場規模（大分子、小分子）、用途別市場規模（がん、糖尿病、心血管疾患、中枢神経系、感染症、筋骨格系）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中...

世界のCISインスリン市場規模・現状・予測（2021年-2027年）

Global CIS Insulin Market Size, Status and Forecast 2021-2027
QYR2104Z1344 2021年4月 93Pages
QYResearch社発行の本調査資料では、CISインスリンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（長時間作用型アナログ、速効型アナログ、プレミックスアナログ、中間インスリン、短時間作用型インスリン、プレミックスインスリン）、用途別市場...

世界の長時間作用性β作動薬市場規模・現状・予測（2021年-2027年） Long-acting beta-agonists or long-acting beta adrenergic receptor agonists are class of drugs used in the management of asthma by relaxing the muscles surrounding the bronchial tubes and facilitating the opening the airways wider. Long-acting beta-agonists have a longer duration of action of at leas…
世界の無菌注射製剤市場 2021：企業別、地域別、種類・用途別 The Sterile Injectables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
世界の小分子標的がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Cancer Therapy Market The global Small Molecule Targeted Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
世界の小分子創薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small-Molecule Drug Discovery Market The global Small-Molecule Drug Discovery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
世界の治療用商品化小分子市場規模・現状・予測（2021年-2027年） Combining next-generation gene sequencing technology with a bioinformatics platform, mainly targeted at genetically defined patients. Market Analysis and Insights: Global Commercialized Small Molecule for Therapy Market The global Commercialized Small Molecule for Therapy market size is projected to…